These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12056172)

  • 1. [Gd(DTPA-BDMA)] as a magnetic resonance contrast agent: acute toxicity test and preliminary images.
    Sheu RS; Wang YM; Kuo YT; Cheng TH; Jaw TS; Liu GC
    Kaohsiung J Med Sci; 2002 Feb; 18(2):77-83. PubMed ID: 12056172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd(DTPA-BBA) as a contrast agent in magnetic resonance imaging in rats.
    Sheu RS; Jaw TS; Wang YM; Liu GC; Kuo YT; Chue PY
    J Formos Med Assoc; 1999 Jan; 98(1):49-55. PubMed ID: 10063274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
    Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
    Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy.
    Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD
    Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between Gd-DTPA and several bisamide derivatives as potential MRI contrast agents.
    Feng J; Sun G; Pei F; Liu M
    Bioorg Med Chem; 2003 Jul; 11(15):3359-66. PubMed ID: 12837545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
    Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative evaluation of CH3-DTPA-Gd (NMS60) for contrast-enhanced magnetic resonance angiography.
    Bammer R; de Crespigny AJ; Howard D; Seri S; Hashiguchi Y; Nakatani A; Moseley ME
    Magn Reson Imaging; 2004 Jun; 22(5):619-24. PubMed ID: 15172054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-mobilizing properties of the gadolinium-DTPA complex: clinical and experimental observations.
    Vorobiov M; Basok A; Tovbin D; Shnaider A; Katchko L; Rogachev B
    Nephrol Dial Transplant; 2003 May; 18(5):884-7. PubMed ID: 12686659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
    Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
    Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
    NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.
    Hijnen NM; Elevelt A; Grüll H
    Invest Radiol; 2013 Jul; 48(7):517-24. PubMed ID: 23695082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent.
    Huang Y; Cao B; Yang X; Zhang Q; Han X; Guo Z
    Magn Reson Imaging; 2013 May; 31(4):604-9. PubMed ID: 23102519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
    Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
    Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.